Kelly, D. A.

The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

Karlsen, T. H., Sheron, N., Zelber-Sagi, S., Carrieri, P., Dusheiko, G., Bugianesi, E., Pryke, R., Hutchinson, S. J., Sangro, B., Martin, N. K., et al. (2022) · The Lancet

Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health Effects

Cited by 652

Indications and outcome of liver transplantation in tyrosinaemia type 1

Mohan, N., McKiernan, P., Kelly, D. A., Preece, M. A., Green, A., Buckels, J., & Mayer, A. D. (1999) · European Journal of Pediatrics

Metabolism and Genetic DisordersOrgan Transplantation Techniques and Outcomes

Cited by 111

Hyperinsulinism in tyrosinaemia type I

Baumann, U., Preece, M. A., Green, A., Kelly, D. A., & McKiernan, P. J. (2005) · Journal of Inherited Metabolic Disease

Metabolism and Genetic DisordersAmino Acid Enzymes and Metabolism

Cited by 54

Cardiomyopathy in tyrosinaemia type I is common but usually benign

Arora, N., Stumper, O., Wright, J., Kelly, D. A., & McKiernan, P. J. (2006) · Journal of Inherited Metabolic Disease

Metabolism and Genetic DisordersLysosomal Storage Disorders Research

Cited by 48